NGS Characterized Biospecimens
Precision for Medicine’s NGS-characterized biospecimens library
Library details
13K+ Biospecimens
23 Oncology indications
Sequenced via :
-
Oncomine precision assay
-
truSighttm oncology 500 assay
Biospecimen types
FFPE blocks: Tumor, normal, and adjacent tissue
H&E images for every biospecimen
Isolated DNA/RNA for most samples
Available data
-
Characterization Data
-
Surgical Pathology Report
-
Histologic Subtype
-
Grade/Stage
-
Demographics
Total specimen counts
Details of Precision’s library of two NGS-characterized biospecimen indications: variant data for lung cancer and colorectal cancer biospecimens
Lung Cancer Biospecimens by Variant
Colorectal Cancer Biospecimens by Variant
Deeper dive Into lung cancer characterization data
Lung Cancer Biospecimens by Cancer Subtype
Colorectal Cancer Biospecimens by Variant
NGS-characterized biospecimens and data available:
1. FFPE Tissue Slides
2. Characterization Data
Below is a table showing examples of some of the data available. Additional (not shown) data include: Surgical procedure, Stage, Demographics, % Tumor, % Necrosis, NGS assay
3. H&E Images
4. DNA/RNA
Additional methods available to analyze and characterize biospecimens
In addition to a selection of high-quality characterized biospecimens, Precision provides specialty lab services to assess these biospecimens using several technologies, including:
-
IHC and mIF
- Leica BOND
- Dako Omnis, Dako Link 48, Artisan
- Ventana BenchMark
- Akoya Phenolmager™ HT
- Pathology Services
-
Digital pathology and slide scanning
- Proscia Concentriq®
- Aperio GT 450
- Aperio AT2
- 3DHISTECH
-
NGS and Genomics
- NGS: multiple platforms
- NanoString
- ddPCR, qPCR
- 10x genomics
Learn more about the uses of characterized biospecimens
Characterized Biospecimens: A Guide for Leveraging Deeply Characterized Biospecimens
Download WhitepaperPrecision’s tissue biospecimen biorepository
Precision’s tissue biorepository contains >3 million FFPE samples and several million histology slides covering a full spectrum of oncologic and medical diseases
Precision’s NGS characterization panels
Precision uses the TruSight™ Oncology 500 (TSO 500) panel and the Oncomine Precision Assay (OPA) panel to characterize oncology biospecimens
TSO 500 Selected Biomarkers
Lung | Melanoma | Colon | Ovary | Breast | Gastric | Bladder | Myeloid | Pan-cancer |
---|---|---|---|---|---|---|---|---|
AKT1 |
BRAF |
AKT1 |
BRAF |
AKT1 |
BRAF |
MSH5 |
ALBL1 |
MSI |
ALK |
CTNNB1 |
BRAF |
BRCA1 |
AR |
KIT |
PMS2 |
ASXL1 |
NTRK |
BRAF |
GNA11 |
HRAS |
BRCA2 |
BRCA1 |
KRAS |
TSC1 |
CALR |
|
DDR2 |
GNAQ |
KRAS |
KRAS |
BRCA2 |
MET |
CESPA |
||
EGFR |
KIT |
MET |
PDGFRA |
ERBB2 |
MLH1 |
ETV6 |
||
ERBB2 |
MAP2K1 |
MLH1 |
FOXL2 |
FGFR1 |
PDGFRA |
EZH2 |
||
FGFR1 |
NF1 |
MSH2 |
TP53 |
FGFR2 |
TP53 |
FLT3 |
||
FGFR3 |
NRAS |
MSH5 |
PIK3CA |
GATA3 |
||||
KRAS |
PDGFRA |
NRAS |
PTEN |
IDH1 |
||||
MAP2K1 |
PIK3CA |
PIK3CA |
IDH2 |
|||||
MET |
PTEN |
PMS2 |
JAK2 |
|||||
NRAS |
TP53 |
PTEN |
KIT |
|||||
PIK3CA |
SMAD4 |
MPL |
||||||
PTEN |
TP53 |
NPM1 |
||||||
RET |
RUNX1 |
|||||||
TP53 |
SF3B1 |
|||||||
TMB |
SRSF2 |
|||||||
TP53 |
OPA Biomarkers
DNA Hotspots
AKT1 | ESR1 | MAP2K2 |
---|---|---|
AKT2 |
FGFR1 |
MET |
AKT3 |
FGFR2 |
MTOR |
ALK |
FGFR3 |
NRAS |
AR |
FGFR4 |
NRTK1 |
ARAF |
FTL3 |
NTRK2 |
BRAF |
GNA11 |
NTRK3 |
CDK4 |
GNAQ |
PDGFRA |
CDKN2A |
GNAS |
PIK3CA |
CHEK2 |
HRAS |
PTEN |
CTNNB1 |
IDH1 |
RAF1 |
EGFR |
IDH2 |
RET |
ERBB2 |
KIT |
ROS1 |
ERBB3 |
KRAS |
SMO |
ERBB4 |
MAP2K1 |
TP53 |
CNV
AKT1 |
---|
AKT2 |
AKT3 |
ALK |
AR |
ARAF |
BRAF |
CDK4 |
CDKN2A |
CHEK2 |
CTNNB1 |
EGFR |
ERBB2 |
ERBB3 |
ERBB4 |
Inter-genetic fusions
ALK | NTRK2 |
---|---|
BRAF |
NTRK3 |
ESR1 |
NUTM1 |
FGFR1 |
RET |
FGFR2 |
ROS1 |
FGRF3 |
RSPO2 |
MET |
RSPO3 |
NRG1 |
- |
NTRK1 |
- |
Intra-genetic fusions
AR |
---|
EGFR |
MET |